Stocks News

LAST PRICE
0.1650
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
0.1600/ 109
Ask / Lots
0.1700/ 6
Open / Previous Close
0.1700 / 0.1650
Day Range
Low 0.1650
High 0.1700
52 Week Range
Low 0.1550
High 0.3100
Volume
82,500
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement, from 7:02AM ET on Wednesday Apr 24, 2024 by Accesswire
  7:02AM ET on Wednesday Apr 24, 2024 by Accesswire
  Companies Mentioned: TLTFF
  TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase^® Technologies Inc. ("Theralase^®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has successfully closed a Non-Brokered Private Placement ("NBPP") offering ("Offering") of units ("Units").
- Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement, from 7:02AM ET on Wednesday Apr 24, 2024 by Dow Jones
  7:02AM ET on Wednesday Apr 24, 2024 by Dow Jones
  Companies Mentioned: TLT
  
  TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase(R) Technologies Inc. ("Theralase(R) " or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has successfully closed a Non-Brokered Private Placement ("NBPP") offering ("Offering") of units ("Units").
Apr 5, 2024
- Theralase(R) Granted Canadian Cancer Vaccine Patent, from 7:02AM ET on Friday Apr 05, 2024 by Accesswire
  7:02AM ET on Friday Apr 05, 2024 by Accesswire
  Companies Mentioned: TLTFF
  TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the safe and effective destruction of various cancers, bacteria and viruses, has been granted a Canadian patent for a new cancer vaccine.
- Theralase(R) Granted Canadian Cancer Vaccine Patent, from 7:02AM ET on Friday Apr 05, 2024 by Dow Jones
  7:02AM ET on Friday Apr 05, 2024 by Dow Jones
  Companies Mentioned: TLT
  
  TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase(R) Technologies Inc. ("Theralase(R)" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the safe and effective destruction of various cancers, bacteria and viruses, has been granted a Canadian patent for a new cancer vaccine.
Mar 27, 2024
- Theralase(R) Release's 4Q2023 Interim Financial Statements, from 7:02AM ET on Wednesday Mar 27, 2024 by Accesswire
  7:02AM ET on Wednesday Mar 27, 2024 by Accesswire
  Companies Mentioned: TLTFF
  TORONTO, ON / ACCESSWIRE / March 27, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the safe and effective destruction of various cancers, bacteria and viruses has released the Company's audited annual consolidated 2023 financial statements ("Financial Statements").

Apr 17, 2024
- Repeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES), from 8:00AM ET on Wednesday Apr 17, 2024 by GlobeNewswire
  8:00AM ET on Wednesday Apr 17, 2024 by GlobeNewswire
  Companies Mentioned: TREIF
- Treatment.com AI Announces New Additions to its Medical Education Suite (MES), from 3:05AM ET on Wednesday Apr 17, 2024 by GlobeNewswire
  3:05AM ET on Wednesday Apr 17, 2024 by GlobeNewswire
  Companies Mentioned: TREIF
Apr 16, 2024
- Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications, from 8:30AM ET on Tuesday Apr 16, 2024 by PR Newswire
  8:30AM ET on Tuesday Apr 16, 2024 by PR Newswire
  Companies Mentioned: PYNKF
Apr 10, 2024
- Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth, from 8:45AM ET on Wednesday Apr 10, 2024 by PR Newswire
  8:45AM ET on Wednesday Apr 10, 2024 by PR Newswire
  Companies Mentioned: LTRN, TREIF, HWAIF
- Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM), from 6:00AM ET on Wednesday Apr 10, 2024 by GlobeNewswire
  6:00AM ET on Wednesday Apr 10, 2024 by GlobeNewswire
  Companies Mentioned: TREIF
Apr 8, 2024
- Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption, from 8:00AM ET on Monday Apr 08, 2024 by GlobeNewswire
  8:00AM ET on Monday Apr 08, 2024 by GlobeNewswire
  Companies Mentioned: TREIF
Apr 5, 2024
- Perimeter Medical Imaging AI to Participate at Annual Meeting of the American Society of Breast Surgeons, from 7:19AM ET on Friday Apr 05, 2024 by MT Newswires
  7:19AM ET on Friday Apr 05, 2024 by MT Newswires
  Companies Mentioned: PINK
Apr 4, 2024
- Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates, from 5:17PM ET on Thursday Apr 04, 2024 by CNW Group
  5:17PM ET on Thursday Apr 04, 2024 by CNW Group
  Companies Mentioned: PYNKF
- Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates, from 5:17PM ET on Thursday Apr 04, 2024 by PR Newswire
  5:17PM ET on Thursday Apr 04, 2024 by PR Newswire
  Companies Mentioned: PYNKF
Mar 28, 2024
- Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update, from 4:01PM ET on Thursday Mar 28, 2024 by PR Newswire
  4:01PM ET on Thursday Mar 28, 2024 by PR Newswire
  Companies Mentioned: PYNKF

Theralase Technologies Inc
TSXV:TLTCanadaView on OTCQB

Search Criteria

Yesterday

Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement, from 7:02AM ET on Wednesday Apr 24, 2024 by Accesswire

Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement, from 7:02AM ET on Wednesday Apr 24, 2024 by Dow Jones

Apr 5, 2024

Theralase(R) Granted Canadian Cancer Vaccine Patent, from 7:02AM ET on Friday Apr 05, 2024 by Accesswire

Theralase(R) Granted Canadian Cancer Vaccine Patent, from 7:02AM ET on Friday Apr 05, 2024 by Dow Jones

Mar 27, 2024

Theralase(R) Release's 4Q2023 Interim Financial Statements, from 7:02AM ET on Wednesday Mar 27, 2024 by Accesswire

Peers Headlines

Apr 17, 2024

Repeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES), from 8:00AM ET on Wednesday Apr 17, 2024 by GlobeNewswire

Treatment.com AI Announces New Additions to its Medical Education Suite (MES), from 3:05AM ET on Wednesday Apr 17, 2024 by GlobeNewswire

Apr 16, 2024

Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications, from 8:30AM ET on Tuesday Apr 16, 2024 by PR Newswire

Apr 10, 2024

Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth, from 8:45AM ET on Wednesday Apr 10, 2024 by PR Newswire

Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM), from 6:00AM ET on Wednesday Apr 10, 2024 by GlobeNewswire

Apr 8, 2024

Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption, from 8:00AM ET on Monday Apr 08, 2024 by GlobeNewswire

Apr 5, 2024

Perimeter Medical Imaging AI to Participate at Annual Meeting of the American Society of Breast Surgeons, from 7:19AM ET on Friday Apr 05, 2024 by MT Newswires

Apr 4, 2024

Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates, from 5:17PM ET on Thursday Apr 04, 2024 by CNW Group

Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates, from 5:17PM ET on Thursday Apr 04, 2024 by PR Newswire

Mar 28, 2024

Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update, from 4:01PM ET on Thursday Mar 28, 2024 by PR Newswire